Loading provider…
Loading provider…
Ophthalmology Physician in Mountain View, CA
NPI: 1053306381Primary Employer
Northern California Retina Vitreous Associates Medical Group, Inc.
ncrva.com
HQ Phone
Get MD James's Phone Numberphone_androidMobile
Get MD James's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1994 - 2027
MA State Medical License
1996 - 1999

American Board of Ophthalmology
Ophthalmology
Stanford University School Of Medicine
med.stanford.edu
Medical School
Until 1992
Massachusetts Eye and Ear Infirmary/Harvard Medical School
Fellowship • Surgical Retina and Vitreous
1996 - 1998
UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye Institutes
Residency • Ophthalmology
1993 - 1996
St Mary's Hospital and Medical Center
Internship • Internal Medicine
1992 - 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 875 | 2,429 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 497 | 509 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 383 | 602 |
| 4 | 67028Injection of drug into eye | 378 | 1,581 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 327 | 558 |
Treat and extend regimen with aflibercept for chronic central retinal vein occlusions: 2 year results of the NEWTON study.
Authors: James Palmer, Mark Wieland, Louis Chang
Publication Date: 2018-12-16
Dexamethasone intravitreal implant for pseudophakic cystoid macular edema in patients with diabetes.
Authors: James Palmer, Mark Wieland, Rahul Khurana
Journal: Ophthalmic Surg Lasers Imaging Retina
THE ASSOCIATION OF EPIRETINAL MEMBRANE WITH MACULAR HOLE FORMATION AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIR.
Authors: Tien Wong, Eric Chen, James Palmer, Louis Chang, James Major, Rahul Khurana, Alok Bansal, Charles Wykoff
Publication Date: 2017-06
Lead Sponsor: Northern California Retina Vitreous Associates
Intervention / Treatment: PROCEDURE: Intravitreal Injection of sulfahexafluoride gas
Lead Sponsor: Regeneron Pharmaceuticals
Collaborators: Bayer
Intervention / Treatment: DRUG: High-dose aflibercept, DRUG: aflibercept